Leaflet HIDROXICLOROCHINA ATB 200mg film-coated tablets


Indicated for: autoimmune diseases; malaria

Route of administration: oral

Substance: hydroxychloroquine (antimalarial)

ATC: P01BA02 (Antiparasitic products, insecticides and repellents | Antimalarials | Aminoquinolines)

Hydroxychloroquine is a medication used to treat malaria, as well as autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. It works by modulating the immune response and inhibiting the growth of malaria parasites.

The medication is taken orally, as directed by a doctor.

Side effects may include nausea, headache, visual disturbances, or skin rashes. In rare cases, severe adverse effects such as retinal damage or cardiac toxicity may occur.

Patients should undergo regular ophthalmologic check-ups during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about HIDROXICLOROCHINA ATB 200mg

  • Substance: hydroxychloroquine
  • Commercial code: W71911001
  • Concentration: 200mg
  • Pharmaceutical form: film-coated tablets
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: ANTIBIOTICE S.A. - ROMANIA
  • Holder: ANTIBIOTICE S.A. - ROMANIA
  • Number: 16641/2026/01
  • Shelf life: 4 years